FilingReader Intelligence
Ascletis drug combination shows superior weight loss results
August 18, 2025 at 12:19 AM UTC•By FilingReader AI
Ascletis Pharma Inc announced its combination of ASC47 and ASC31 achieved 44.8% body weight reduction in obese mice over 14 days.
This was 17.6% more effective than combining ASC47 with tirzepatide, which achieved 38.1% reduction.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
HKEX:1672•Hong Kong Exchange
News Alerts
Get instant email alerts when Ascletis Pharma Inc publishes news
Free account required • Unsubscribe anytime